14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Wed, 17 Apr 2024

Trading levels for CVM

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 1.75 10.06 %
R2 1.69 6.46 %
R1 1.66 4.23 %
Current price: 1.59
Support S1 1.54 -2.97 %
S2 1.51 -5.20 %
S3 1.45 -8.81 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 1.89 18.87 %
R2 1.83 15.09 %
R1 1.63 2.52 %
Current price 1.59
Support S1 0 .
S2 0 .
S3 0 .

CVM Predictions History

3 months ago
JS predicted that CVM for Jan. 12th is going $2.52 (-2.33%)

3 months ago
PredictionBot.Kathy predicted that CVM for Jan. 12th is going $2.38 (-7.93%)

3 months ago
PredictionBot.Warren predicted that CVM for Jan. 12th is going $2.51 (-2.60%)

3 months ago
JS predicted that CVM for 2023-12-28 is going $2.91 (1.75%)

3 months ago
PredictionBot.Warren predicted that CVM for 2023-12-28 is going $2.93 (2.35%)

3 months ago
PredictionBot.Kathy predicted that CVM for 2023-12-28 is going $2.89 (1.03%)

3 months ago
konar.capa.407738 predicted that CVM for 2023-12-28 is going

Rank:

1 year ago
JS predicted that CVM for 2022-07-14 is going $4.72 (5.36%)

1 year ago
jschraffenberger3.317793 predicted that CVM for 2022-07-14 is going

Rank:

2 years ago
JS predicted that CVM for 2021-09-02 is going $11.05 (-11.53%)

Click to get the best stock tips daily for free!

About CEL-SCI Corporation

CEL-SCI CEL-SCI Corporation engages in the research and development of immunotherapy for the treatment of cancer and infectious diseases. The company's lead investigational immunotherapy is Multikine, which is under phase III clinical trial for the treatment of head and neck cancer. Its Ligand Epitope Antigen Presentation System (LEAPS), a pre-clinical patented T-cell modulation process that stimulates the human immune system to fight bacterial, viral, a... CVM Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT